About

Coronary artery disease (CAD) is one of the most common causes of death worldwide. It is responsible for one-third of deaths in people over 35 years old, with the percentage reaching close to 50% (according to some estimates) in western countries.

The existing treatment is medical, surgical or a combination of both depending on the extent, severity and clinical presentation of CAD & .There has been significant progress made in developing novel strategies for patients suffering from CAD and its associated complications. These strategies have ranged from drugs to robotic surgery to nanotechnology.

Articles

Management of Severe Dyslipidaemia: Role of PCSK9 Inhibitors

Citation:

European Cardiology Review 2018;13(1):9–13.

Familial Hypercholesterolaemia Diagnosis and Management

Citation:

European Cardiology Review 2018;13(1):14–20.

Nicorandil and Long-acting Nitrates: Vasodilator Therapies for the Management of Chronic Stable Angina Pectoris

Citation:

European Cardiology Review 2018;13(1):23–8.

Role of Anti-inflammatory Interventions in Coronary Artery Disease: Understanding the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)

Citation:

European Cardiology Review 2018;13(1):38–41.